These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1408727)

  • 61. A campaign to raise awareness of microalbuminuria screening.
    Daly H
    Prof Nurse; 2004 Jan; 19(5):275. PubMed ID: 14737801
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Diabetic nephropathy and cardiac disease].
    Gross JL; Silveiro SP; Canani LH; Friedman R; Leitão CB; Azevedo MJ
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):244-56. PubMed ID: 17505631
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor.
    Weir MR
    J Clin Hypertens (Greenwich); 2004 Mar; 6(3):134-41; quiz 142-3. PubMed ID: 15010646
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lack of familial predisposition to cardiovascular disease in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Nørgaard K; Mathiesen ER; Hommel E; Jensen JS; Parving HH
    Diabetologia; 1991 May; 34(5):370-2. PubMed ID: 1864492
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Monitoring diabetic nephropathy by the determination of microalbuminuria].
    Krempf M; Ricolleau G; Murat A; du Rostu H; Charbonnel B; Guillon J
    Presse Med; 1984 Dec; 13(46):2817. PubMed ID: 6240655
    [No Abstract]   [Full Text] [Related]  

  • 66. Microalbuminuria: measurements, determinants and accompaniments.
    Ganda OP
    Diabetes Res Clin Pract; 1991 Mar; 11(3):137-9. PubMed ID: 2036935
    [No Abstract]   [Full Text] [Related]  

  • 67. Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus.
    Gilbert RE; Cooper ME; McNally PG; O'Brien RC; Taft J; Jerums G
    Diabet Med; 1994; 11(7):636-45. PubMed ID: 7955987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hypotensive therapy in diabetic renal disease.
    Czekalski S
    Przegl Lek; 1998; 55 Suppl 1():62-4. PubMed ID: 9857701
    [No Abstract]   [Full Text] [Related]  

  • 69. [What values should be used to diagnose microalbuminuria in patients with diabetes mellitus?].
    Leitão CB; Canani LH; Bolson PB; Molon MP; Silveiro SP; Gross JL
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):322-6. PubMed ID: 16767298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is Change in Albuminuria a Surrogate Marker for Cardiovascular and Renal Outcomes in Type 1 Diabetes?
    Dixon BS
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1921-1923. PubMed ID: 27797905
    [No Abstract]   [Full Text] [Related]  

  • 71. Expert consensus on management of diabetic patients with impairment of renal function.
    Bonnet F; Gauthier E; Gin H; Hadjadj S; Halimi JM; Hannedouche T; Rigalleau V; Romand D; Roussel R; Zaoui P
    Diabetes Metab; 2011 Sep; 37 Suppl 2():S1-25. PubMed ID: 22108432
    [No Abstract]   [Full Text] [Related]  

  • 72. The predictive value of microalbuminuria.
    Steffes MW; Chavers BM; Bilous RW; Mauer SM
    Am J Kidney Dis; 1989 Jan; 13(1):25-8. PubMed ID: 2912061
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Causes of renal failure in patients with type 2 diabetes mellitus.
    Onuigbo MA
    JAMA; 2003 Oct; 290(14):1855; author reply 1855-6. PubMed ID: 14532312
    [No Abstract]   [Full Text] [Related]  

  • 74. [Antihypertensive treatment in diabetic nephropathy].
    Mogensen CE
    Nord Med; 1979 Nov; 94(11):292. PubMed ID: 492961
    [No Abstract]   [Full Text] [Related]  

  • 75. The natural history of diabetic nephropathy.
    Tuttle KR; Stein JH; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):184-93. PubMed ID: 2190276
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Who's on first? Does hypertension in type I diabetics result from nephropathy or metabolic alterations?
    Hinderliter AL; Runge MS
    Circulation; 2001 Jul; 104(5):508-10. PubMed ID: 11479244
    [No Abstract]   [Full Text] [Related]  

  • 77. Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy.
    Sasso FC; De Nicola L; Carbonara O; Nasti R; Minutolo R; Salvatore T; Conte G; Torella R
    Diabetes Care; 2006 Mar; 29(3):498-503. PubMed ID: 16505495
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natural history and pathogenesis of diabetic nephropathy.
    Viberti G; Walker JD
    J Diabet Complications; 1991; 5(2-3):72-5. PubMed ID: 1770057
    [No Abstract]   [Full Text] [Related]  

  • 79. Microalbuminuria.
    Hindmarsh JT
    Clin Lab Med; 1988 Sep; 8(3):611-6. PubMed ID: 3048860
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Diabetic nephropathy and cardiovascular risk].
    Avila Lachica L; Gómez García MC
    Aten Primaria; 2010 Mar; 42(3):173-5. PubMed ID: 19647899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.